I am organizing a regulatory panel for the World Biomaterials Congress, in Montreal, Canada, May 18-22, 2016. The panel session, "Biomaterials & Medical Products Commercialization: Regulatory Case Studies – How to Get to Market?" is planned for Friday, May 20 at 4:30pm.
My colleague and I are searching for interested regulatory professionals to sit on the panel discussion in the session. The plan is to have several regulatory case studies that we'll explain, give multiple choice answers, have the audience vote, then have the panel explain the rationale for their choices. The panel will get the questions several weeks in advance to prepare answers/talking points. These case studies will introduce situations which many biomaterial developers face, including implementing quality systems, choosing biocompatibility testing, getting approval for First in Man studies, larger clinical trials, and bringing a product with a new material/feature to market. There is no compensation for this panel, other than our gratitude and networking possibilities with the international biomaterials community.
Please let me know if you or anyone you know would be interested in participating in this international conference session.
Conference website:
http://wbc2016.org/
Julie Leslie, PhD
Manager, Regulatory Affairs, Neuromodulation
USA
O +1 281 727 2672
F +1 281 853 1292
julie.leslie@livanova.com
www.livanova.com
Cyberonics
100 Cyberonics Blvd
Houston, TX 77058
"This email has been sent by or on behalf of one or more of LivaNova PLC (registered in England and Wales with registered no. 09451374) with its registered office address at 5 Merchant Square - North Wharf Road - London - W2 1AY, or one of its subsidiaries. This message may contain confidential or privileged information intended only for the use of the addressee(s), and may also contain sensitive patient-related information protected by state and federal laws. If you are not the intended recipient of this message, or an authorized representative of the intended recipient, you are prohibited from reviewing, copying, or distributing this message, its attachments, or any information contained in this message. If you received this message in error, please notify the sender immediately by replying to the sender and delete this message from your system immediately hereafter."